Overcoming Acquired Resistance to TRAIL by Chemotherapeutic Agents and Calpain Inhibitor I through Distinct Mechanisms

This publication has 27 references indexed in Scilit:

• Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line
  Gene Therapy, 2002
• An Inducible Pathway for Degradation of FLIP Protein Sensitizes Tumor Cells to TRAIL-induced Apoptosis
  Journal of Biological Chemistry, 2002
• Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression
  Oncogene, 2002
• Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer
  Oncogene, 2001
• Synergistic Induction of Apoptosis by the Combination of TRAIL and Chemotherapy in Chemoresistant Ovarian Cancer Cells
  Gynecologic Oncology, 2001
• Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan
  Cell Death & Differentiation, 2000
• Inhibition of NF-κB Activity Enhances TRAIL Mediated Apoptosis in Breast Cancer Cell Lines
  Breast Cancer Research and Treatment, 2000
• Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
  Proceedings of the National Academy of Sciences, 2000
• Safety and antitumor activity of recombinant soluble Apo2 ligand
  Journal of Clinical Investigation, 1999
• Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo
  Nature Medicine, 1999